🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lucas Blanchard

Laboratory of Molecular Genetics

ORCID: 0000-0001-6942-7086

Also affiliated with Rockefeller University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer”.

Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer

Cancer Cell(2025)10.1016/j.ccell.2025.07.013
N/A
0.524DataRank · unranked
32 citations

David A. Knorr, Polina Weitzenfeld, Lucas Blanchard, Ning Yao, Maria Baez +10 more

Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102141
N/A
0.385DataRank · unranked
12 citations

Estefania Vina, Jerko Ljubetic, Cécile Meneur, Dorian Tarroux, Maria Baez +6 more

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

Cancer Immunology Research(2023)10.1158/2326-6066.cir-23-0389
N/A
0DataRank · unranked
31 citations

Lucas Blanchard, Rom S. Leidner, Shawn M. Jensen, Ryan Meng, Andrew Jones +12 more

Targeting Myeloid Cells for Cancer Immunotherapy

Cancer Immunology Research(2025)10.1158/2326-6066.cir-25-0159
N/A
0DataRank · unranked
10 citations

Andrew Mijacika, Juan C. Osorio, Lucas Blanchard